FindTrial
Sign In

A prospective cohort study on maternal-infant immune allergies and children's growth and development

A prospective cohort study on maternal-infant immune allergies and children's growth and development

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128774
Enrollment
Unknown
Registered
2026-07-25
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Interventions

Pregnant women follow-up group
Offspring follow-up group:None

Sponsors

Xuzhou Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent form to participate in this study, have established a medical record at Xuzhou Maternal and Child Health Hospital and plan to receive antenatal care and give birth at this hospital, with the first antenatal visit at gestational age =14 weeks. 2. Able to understand and complete questionnaires, and willing to adhere to the follow-up from 0 to 3 years of age.

Exclusion criteria

Exclusion criteria: Patients with severe mental disorders or severe acute/chronic illnesses who are unable to complete follow-up due to reasons such as hospital transfer or relocation.

Design outcomes

Primary

MeasureTime frame
Maternal transfer antibodies;Inflammatory cytokines;Neurocognitive development;—

Countries

China

Contacts

Public ContactPeng Lei

Xuzhou Maternity and Child Health Care Hospital

xzfypl@163.com+86 516 83811194

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026